Johnson & Johnson Expands Neuroscience Portfolio by Acquiring Intra-Cellular Therapies
Cytovance and PolyPeptide Unite to Accelerate Peptide Drug Innovations
J&J Acquires Intra-Cellular Therapies for $14.6 Billion, Strengthening Neuroscience Portfolio
GSK Acquires IDRx to Expand GIST Treatment Options
Eckert & Ziegler, GlyTherix Expand Partnership with Actinium-225 Agreement
Eckert & Ziegler Partners with GlyTherix to Supply Actinium-225 for Cancer Treatment
Gilead and LEO Pharma Team Up to Develop Oral STAT6 Treatments for Inflammatory Diseases
Royalty Pharma Projects $2.8 Billion in 2024 Portfolio Receipts
Zai Lab Partners with Vertex to Launch Pove in Asian Markets
Pacira Launches 5×30 Growth Plan, Reports $701M Revenue for 2024
Zai Lab Joins Forces with MediLink to Advance Cancer Drug ZL-6201
Madagascar Boosts COVID Vaccine Uptake with Community-Driven Strategy
HERA Launches Stakeholders Hub Enhancing EU Pharma Collaboration
Coave Therapeutics Raises $33 Million Series A to Propel Genetic Medicine Innovations